RBWA
MDLN

RFG - Bristol Wealth Advisors’s Medline Inc MDLN Stock Holding History

RFG - Bristol Wealth Advisors’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,690
Closed -$565K – 194
2026
Q1 		$565K Buy
+12,690
New +$560K 0.15% 100

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
ECU
Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RFG - Bristol Wealth Advisors's MDLN Position: Q2 2026 in Review

RFG - Bristol Wealth Advisors sold out of Medline Inc (MDLN) in Q2 2026, closing a stake of 12,690 shares — an estimated $565K sold.

RFG - Bristol Wealth Advisors first reported a position in MDLN in Q1 2026 and held it in 1 quarter. The position peaked at $565K in Q1 2026. 230 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • RFG - Bristol Wealth Advisors reported no remaining Medline Inc position as of Q2 2026 after selling out during the quarter.
  • RFG - Bristol Wealth Advisors sold 12,690 Medline Inc shares in Q2 2026, an estimated $565K.
  • RFG - Bristol Wealth Advisors first reported a position in Medline Inc in Q1 2026 and held it in 1 quarter.
  • RFG - Bristol Wealth Advisors's Medline Inc position peaked at $565K in Q1 2026.
  • 230 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on RFG - Bristol Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.